Search

NIAID Issues BAA for Bio-Defense Vaccine Enhancement

The National Institute of Allergy and Infectious Diseases (NIAID), with funding provided in whole or in part by the Biomedical Advanced Research and Development Agency, plans to fund organizations with demonstrated vaccine product development experience to produce a vaccine candidate either for a NIAID Category A or B Priority Pathogen or a candidate third generation anthrax vaccine. Sol. No. BAA-NIH-BARDA-NIAID-DMID-AI2007007. Respond by Jan. 22, 2008. Contact: Jordan Pulaski, contract specialist, 301-451-480-4675, jpulaski@niaid.nih.gov.

Subscriber-only content. Please log in below.

Not a subscriber or registered user yet?

Please contact us at clientservices@accessintel.com or call us at 888-707-5814 (Monday – Thursday 9:00 a.m. – 5:30 p.m. and Friday 9:00 a.m. – 3:00 p.m. ET.), to start a free trial, get pricing information, order a reprint, or post an article link on your website.

Congress Updates

House Heads For Recess Without Moving On NDAA After Procedural Vote Fails

The House will leave for the Fourth of July recess without moving forward on its $1.15 trillion fiscal year 2027 National Defense Authorization Act (NDAA), with a procedural vote to […]


Bipartisan Group Of House Members Introduce U.S.-Ukrainian Co-Production Bill For Unmanned Systems

A bipartisan group of six House legislators have introduced the Strategic Unmanned Systems Partnership Act–a bill to improve drone collaboration between the U.S. and Ukraine. Rep. Michael McCaul (R-Texas), the […]


Will $4 Billion For SB-AMTI/Space Data Network Backbone In Supplemental Reduce Or Add To Planned Funding For Systems In Reconciliation?

Nearly all of the Department of the Air Force’s fiscal 2027 procurement and research and development (R&D) budget for space-based air moving target indication (SB-AMTI) and the Space Data Network […]


House Appropriators ‘Concerned’ With JLTV A2 Delays, Shift Funds For Marines’ Second Supplier Effort

House appropriators have said they’re “seriously concerned” with Joint Light Tactical Vehicle (JLTV) A2 delays, as their fiscal year 2027 defense spending bill shifts funds to support the Marine Corps’ […]